Effects of sildenafil in Nω-nitro-l-arginine methyl ester-induced intrauterine growth restriction in a rat model

American Journal of Perinatology

Volumn 29, Issue 6, 2012, Pages 429-434

  Nassar, Anwar H ^a   Masrouha, Karim Z ^a   Itani, Hana ^a   Nader, Khalil Abi ^a   Usta, Ihab M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

intrauterine growth restriction; L NAME; preeclampsia; rat model; sildenafil citrate

Indexed keywords

N(G) NITROARGININE METHYL ESTER; SILDENAFIL;

ANIMAL EXPERIMENT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FETUS; HYSTEROTOMY; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STILLBIRTH;

ANIMALS; BIRTH WEIGHT; DISEASE MODELS, ANIMAL; FEMALE; FETAL GROWTH RETARDATION; NG-NITROARGININE METHYL ESTER; PIPERAZINES; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; PURINES; RATS; RATS, SPRAGUE-DAWLEY; SULFONES; VASODILATOR AGENTS;

EID: 84861230430     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0032-1304823     Document Type: Article

References (44)

1. Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev: 2009; 6 03 332 336
2. Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol: 2003; 110 01 S99 S107 (Pubitemid 37072147)
3. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A.; The Vermont Oxford Network. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. Am J Obstet Gynecol: 2000; 182 1 Pt 1 198 206 (Pubitemid 30074392)
4. van Wassenaer A. Neurodevelopmental consequences of being born SGA. Pediatr Endocrinol Rev: 2005; 2 372 377 (Pubitemid 40469500)
5. Barker DJ, Eriksson JG, Forsn T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol: 2002; 31 1235 1239 (Pubitemid 36204489)
6. Takei H, Nakai Y, Hattori N., et al. The herbal medicine Toki-shakuyaku-san improves the hypertension and intrauterine growth retardation in preeclampsia rats induced by Nomega-nitro-L-arginine methyl ester. Phytomedicine: 2004; 11 43 50 (Pubitemid 38196795)
7. Pan SL, Yu YH. [Establishment of a new rat model of intrauterine growth retardation]. J First Mil Med Univ: 2002; 22 339 340, 343
8. Sasaki J, Fukami E, Mimura S, Hayakawa M, Kitoh J, Watanabe K. Abnormal cerebral neuronal migration in a rat model of intrauterine growth retardation induced by synthetic thromboxane A(2). Early Hum Dev: 2000; 58 91 99 (Pubitemid 30347389)
9. Regnault TR, Orbus RJ, de Vrijer B., et al. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR). Placenta: 2002; 23 132 144 (Pubitemid 41110512)
10. Rutland CS, Mukhopadhyay M, Underwood S, Clyde N, Mayhew TM, Mitchell CA. Induction of intrauterine growth restriction by reducing placental vascular growth with the angioinhibin TNP-470. Biol Reprod: 2005; 73 1164 1173 (Pubitemid 41698606)
11. Mayr AJ, Lederer W, Wolf HJ, Dünser M, Pfaller K, Mörtl MG. Morphologic changes of the uteroplacental unit in preeclampsia-like syndrome in rats. Hypertens Pregnancy: 2005; 24 29 37 (Pubitemid 40411274)
12. Buhimschi IA, Shi SQ, Saade GR, Garfield RE. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies. Am J Obstet Gynecol: 2001; 184 686 693 (Pubitemid 32234985)
13. Villanueva-Garca D, Mota-Rojas D, Hernndez-Gonzlez R., et al. A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour. J Obstet Gynaecol: 2007; 27 255 259 (Pubitemid 46676394)
14. Zoma WD, Baker RS, Clark KE. Effects of combined use of sildenafil citrate (Viagra) and 17beta-estradiol on ovine coronary and uterine hemodynamics. Am J Obstet Gynecol: 2004; 190 1291 1297 (Pubitemid 38692211)
15. Refuerzo JS, Sokol RJ, Aranda JV., et al. Sildenafil citrate and fetal outcome in pregnant rats. Fetal Diagn Ther: 2006; 21 259 263
16. Lacassie HJ, Germain AM, Valds G, Fernndez MS, Allamand F, Lpez H. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol: 2004; 103 5 Pt 2 1118 1120
17. Lynch TD, Laffey JG. Sildenafil for pulmonary hypertension in pregnancy? Anesthesiology: 2006; 104 2 382
18. Molelekwa V, Akhter P, McKenna P, Bowen M, Walsh K. Eisenmenger's syndrome in a 27 week pregnancymanagement with bosentan and sildenafil. Ir Med J: 2005; 98 87 88 (Pubitemid 40514634)
19. Briganti A, Salonia A, Deho' F., et al. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction. World J Urol: 2005; 23 374 384 (Pubitemid 43124388)
20. Noori S, Friedlich P, Wong P, Garingo A, Seri I. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Neonatology: 2007; 91 92 100
21. Leibovitch L, Matok I, Paret G. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension. Drugs: 2007; 67 57 73 (Pubitemid 46105087)
22. Nagdyman N, Fleck T, Bitterling B., et al. Influence of intravenous sildenafil on cerebral oxygenation measured by near-infrared spectroscopy in infants after cardiac surgery. Pediatr Res: 2006; 59 462 465 (Pubitemid 43740089)
23. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol: 1989; 161 1200 1204 (Pubitemid 20007682)
24. Miller SL, Loose JM, Jenkin G, Wallace EM. The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus. Am J Obstet Gynecol: 2009; 200 102, e1-e7
25. Pinheiro da Costa BE, Scocco C, Poli de Figueiredo CE, Guimares JA. Increased serum phosphodiesterase activity in women with pre-eclampsia. BJOG: 2006; 113 577 579
26. Wareing M, Myers JE, O'Hara M., et al. Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and pre-eclampsia. Eur J Obstet Gynecol Reprod Biol: 2006; 127 41 49 (Pubitemid 43947425)
27. Wareing M, Myers JE, O'Hara M, Baker PN. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab: 2005; 90 2550 2555 (Pubitemid 40686290)
28. Khan RN, Hamoud H, Warren A, Wong LF, Arulkumaran S. Relaxant action of sildenafil citrate (Viagra) on human myometrium of pregnancy. Am J Obstet Gynecol: 2004; 191 315 321 (Pubitemid 39077995)
29. Snchez-Aparicio P, Mota-Rojas D, Nava-Ocampo AA., et al. Effects of sildenafil on the fetal growth of guinea pigs and their ability to survive induced intrapartum asphyxia. Am J Obstet Gynecol: 2008; 198 127, e1-e6
30. Sasser JM, Baylis C. Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy. Am J Physiol Regul Integr Comp Physiol: 2010; 298 R433 R438
31. Ramesar SV, Mackraj I, Gathiram P, Moodley J. Sildenafil citrate improves fetal outcomes in pregnant, L-NAME treated, Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol: 2010; 149 22 26
32. Pellicer B, Herraiz S, Cauli O., et al. Haemodynamic effects of long-term administration of sildenafil in normotensive pregnant and non-pregnant rats. BJOG: 2011; 118 615 623
33. Thaete LG, Kushner DM, Dewey ER, Neerhof MG. Endothelin and the regulation of uteroplacental perfusion in nitric oxide synthase inhibition-induced fetal growth restriction. Placenta: 2005; 26 242 250 (Pubitemid 40247013)
34. Sellman JE, DeRuisseau KC, Betters JL., et al. In vivo inhibition of nitric oxide synthase impairs upregulation of contractile protein mRNA in overloaded plantaris muscle. J Appl Physiol: 2006; 100 258 265 (Pubitemid 43671116)
35. Bahtiyar MO, Buhimschi C, Ravishankar V., et al. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction. Am J Obstet Gynecol: 2007; 196 72, e1-e6
36. Buhimschi C, Buhimschi I, Yallampalli C, Chwalisz K, Garfield RE. Contrasting effects of diethylenetriamine-nitric oxide, a spontaneously releasing nitric oxide donor, on pregnant rat uterine contractility in vitro versus in vivo. Am J Obstet Gynecol: 1997; 177 690 701 (Pubitemid 27413789)
37. Nicolaides KH, Campbell S, Bradley RJ, Bilardo CM, Soothill PW, Gibb D. Maternal oxygen therapy for intrauterine growth retardation. Lancet: 1987; 1 942 945 (Pubitemid 17055966)
38. Battaglia C, Artini PG, D'Ambrogio G, Galli PA, Segre A, Genazzani AR. Maternal hyperoxygenation in the treatment of intrauterine growth retardation. Am J Obstet Gynecol: 1992; 167 430 435
39. Say L, Gülmezoglu AM, Hofmeyr GJ. Maternal oxygen administration for suspected impaired fetal growth. Cochrane Database Syst Rev: 2003; CD000137
40. ECPPA Collaborative Group. ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Preveno da Pr-eclampsia com Aspirina) Collaborative Group. Br J Obstet Gynaecol: 1996; 103 39 47
41. Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev: 2004; 1 CD004659
42. Takei H, Iizuka S, Yamamoto M, Takeda S, Yamamoto M, Arishima K. The herbal medicine Tokishakuyakusan increases fetal blood glucose concentrations and growth hormone levels and improves intrauterine growth retardation induced by N(omega)-nitro-L-arginine methyl ester. J Pharmacol Sci: 2007; 104 319 328 (Pubitemid 47378419)
43. Tsukimori K, Komatsu H, Fukushima K, Kaku T, Nakano H, Wake N. Inhibition of nitric oxide synthetase at mid-gestation in rats is associated with increases in arterial pressure, serum tumor necrosis factor-alpha, and placental apoptosis. Am J Hypertens: 2008; 21 477 481 (Pubitemid 351450855)
44. Chen D, Wang H, Huang H, Dong M. Vascular endothelial growth factor attenuates Nomega-nitro-L-arginine methyl ester-induced preeclampsia-like manifestations in rats. Clin Exp Hypertens: 2008; 30 606 615